Biocrates provides the fast track to metabolic biomarker signatures.
With targeted metabolomics kits and services for quantitative, reproducible, and high throughput analyses, Biocrates enables researchers to acquire comprehensive metabolic information more quickly, and more reliably.
Biocrates is the partner of choice for Metabolic Phenotyping.
Miolo et al., Oncotarget (2016)Phamacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers...The tryptophan to spermidine ratio predicts response to HER2+ breast cancer therapy.
Atelier Waters / Biocrates User Meeting07 Oct 2016
Society for Neuroscience12-16 Oct 2016
Helmholtz Metabolomics Symposium: "Diabetes and Cancer"27 Oct 2016
Copyright © 2012-2014 Biocrates Life Sciences AG, Eduard-Bodem-Gasse 8, 6020 Innsbruck, Austria
Terms & Conditions | Impressum